Company Overview and News

 
Boeing, Home Depot Weigh on Dow Tuesday

14h 247wallst
May 22, 2018: Markets opened higher again Tuesday but it’s been a bumpy day ever since, especially for the blue chips. Trading has been mixed all day with the energy sector the day’s biggest loser while financials and utilities have performed best. The FOMC releases the tea leaves, uh, minutes, of its latest meeting tomorrow. A slightly weakening dollar and still-high 10-year yields pretty much offset each other.

 
3 Stocks to Buy for a Strong Summer Vacation Season | InvestorPlace

16h investorplace
Summer vacation is just around the corner. For most of us, that represents some potential rest. But savvy investors are looking for summer vacation stocks.

 
Huntington Ingalls Industries: Stock Pullback Creates A Buying Opportunity

18h seekingalpha
A good 2018 first quarter but the stock has pulled back due to putting cash into the pension fund and missing analyst EPS consensus.

 
Boeing Secures Navy Deal to Modernize F/A-18 & EA-18G Jets

18h zacks
The Boeing Company (BA - Free Report) recently won a task order to support F/A-18 A-F and EA-18G aircrafts for the U.S. Navy and the government of Australia. Work related to the deal is scheduled to be over by July 2022.

 
What Is General Electric Company Stock Worth in a Breakup? | InvestorPlace

19h investorplace
As shares of General Electric Company (NYSE:GE) have plunged, the calls for a breakup have grown louder. Bulls see the true value of GE stock as clouded by issues at GE Capital and weakness in divisions such as Lighting and Transportation. With two still-growing businesses — Aviation and Healthcare — plus a 62.5% stake in Baker Hughes a GE Co (NYSE:BHGE), optimists argue there has to be some value in General Electric stock, particularly after a 50%-plus decline from 2016 highs.

 
Sector ETFs & Stocks to Surge As US-China Trade Fear Ebbs

20h zacks
Wall Street’s biggest dampener for the last few months will be offset now as the United States and China put trade war on hold. The world’s largest economies dropped their tariff threats and set up a framework to address potential trade imbalances in the future. China has promised to purchase more U.S. goods and services, including energy and agricultural products that would support growth and employment in the United States.

 
US-China Work Out Trade Truce: 5 Top Winners

20h zacks
The United States and China have agreed to “substantially” lessen trade deficit following two days of negotiations. China promised to “significantly” purchase U.S. goods and services that soothed investors’ nerves to a fair extent.

 
4 Blue-Chip Stocks Rallying on a U.S.-China Trade Deal | InvestorPlace

21h investorplace
U.S. equities were on a roll on Monday that looks set to continue Tuesday, with the Dow Jones Industrial Average crossing the 25,000 threshold for the first time since March.

 
Trade Wars Are Easy To Win: Never Mind, Trade War On Hold

21h seekingalpha
It now appears that some trade wars are not really trade wars at all, but starting bargaining positions.

 
Trade War Relief Rally - Cramer's Mad Money (5/21/18)

22h seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, May 21.

 
Australia investigators defend MH370 out-of-control scenario

2018-05-22 channelnewsasia
SYDNEY: Australian investigators on Tuesday (May 22) defended their findings that missing Malaysia Airlines flight MH370 was out of control when it plunged into the ocean, despite renewed theories that a rogue pilot ditched the plane.

 
H.B. Fuller Is An Under-Appreciated Transformation Story

2018-05-22 seekingalpha
Underappreciated transformation story driven by a multi-year restructuring focused on cost-savings and a strategic shift to higher value products.

 
6 Mostt Important Things In Business Today

2018-05-22 247wallst
China, in the early stages of a trade war with the U.S., said is would lower some tariffs. According to CNBC:

 
Asian markets mostly lower after Wall Street gains

2018-05-22 nzherald.co.nz
BEIJING (AP) — Asian markets were mostly lower Tuesday after Wall Street gained as Italy moved toward forming a euroskeptic-led government.

 
PRESS DIGEST -Wall Street Journal - May 22

2018-05-22 reuters
May 22 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 097023105